Abstract
Sixty-nine patients who underwent primary percutaneous coronary intervention within 12 hours after onset of acute myocardial infarction were randomized to receive intracoronary injection of autologous bone marrow mesenchymal stem cell or standard saline. Several imagining techniques demonstrated that bone marrow mesenchymal stem cells significantly improved left ventricular function.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Angioplasty, Balloon, Coronary*
-
Echocardiography
-
Female
-
Humans
-
Injections, Intralesional
-
Male
-
Mesenchymal Stem Cells*
-
Middle Aged
-
Myocardial Infarction / diagnostic imaging
-
Myocardial Infarction / therapy*
-
Stem Cell Transplantation*
-
Treatment Outcome
-
Ventricular Dysfunction, Left / diagnostic imaging
-
Ventricular Dysfunction, Left / therapy*
-
Ventricular Remodeling